Cargando…
Design and Functional Analysis of Heterobifunctional Multivalent Phage Capsid Inhibitors Blocking the Entry of Influenza Virus
[Image: see text] Multiple conjugation of virus-binding ligands to multivalent carriers is a prominent strategy to construct highly affine virus binders for the inhibition of viral entry into host cells. In a previous study, we introduced rationally designed sialic acid conjugates of bacteriophages...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305970/ https://www.ncbi.nlm.nih.gov/pubmed/35759354 http://dx.doi.org/10.1021/acs.bioconjchem.2c00166 |
_version_ | 1784752446368645120 |
---|---|
author | Adam, Lutz Müller, Eva Ludwig, Kai Klenk, Simon Lauster, Daniel Liese, Susanne Herrmann, Andreas Hackenberger, Christian P. R. |
author_facet | Adam, Lutz Müller, Eva Ludwig, Kai Klenk, Simon Lauster, Daniel Liese, Susanne Herrmann, Andreas Hackenberger, Christian P. R. |
author_sort | Adam, Lutz |
collection | PubMed |
description | [Image: see text] Multiple conjugation of virus-binding ligands to multivalent carriers is a prominent strategy to construct highly affine virus binders for the inhibition of viral entry into host cells. In a previous study, we introduced rationally designed sialic acid conjugates of bacteriophages (Qβ) that match the triangular binding site geometry on hemagglutinin spike proteins of influenza A virions, resulting in effective infection inhibition in vitro and in vivo. In this work, we demonstrate that even partially sialylated Qβ conjugates retain the inhibitory effect despite reduced activity. These observations not only support the importance of trivalent binding events in preserving high affinity, as supported by computational modeling, but also allow us to construct heterobifunctional modalities. Capsids carrying two different sialic acid ligand–linker structures showed higher viral inhibition than their monofunctional counterparts. Furthermore, capsids carrying a fluorescent dye in addition to sialic acid ligands were used to track their interaction with cells. These findings support exploring broader applications as multivalent inhibitors in the future. |
format | Online Article Text |
id | pubmed-9305970 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-93059702022-07-23 Design and Functional Analysis of Heterobifunctional Multivalent Phage Capsid Inhibitors Blocking the Entry of Influenza Virus Adam, Lutz Müller, Eva Ludwig, Kai Klenk, Simon Lauster, Daniel Liese, Susanne Herrmann, Andreas Hackenberger, Christian P. R. Bioconjug Chem [Image: see text] Multiple conjugation of virus-binding ligands to multivalent carriers is a prominent strategy to construct highly affine virus binders for the inhibition of viral entry into host cells. In a previous study, we introduced rationally designed sialic acid conjugates of bacteriophages (Qβ) that match the triangular binding site geometry on hemagglutinin spike proteins of influenza A virions, resulting in effective infection inhibition in vitro and in vivo. In this work, we demonstrate that even partially sialylated Qβ conjugates retain the inhibitory effect despite reduced activity. These observations not only support the importance of trivalent binding events in preserving high affinity, as supported by computational modeling, but also allow us to construct heterobifunctional modalities. Capsids carrying two different sialic acid ligand–linker structures showed higher viral inhibition than their monofunctional counterparts. Furthermore, capsids carrying a fluorescent dye in addition to sialic acid ligands were used to track their interaction with cells. These findings support exploring broader applications as multivalent inhibitors in the future. American Chemical Society 2022-06-27 2022-07-20 /pmc/articles/PMC9305970/ /pubmed/35759354 http://dx.doi.org/10.1021/acs.bioconjchem.2c00166 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Adam, Lutz Müller, Eva Ludwig, Kai Klenk, Simon Lauster, Daniel Liese, Susanne Herrmann, Andreas Hackenberger, Christian P. R. Design and Functional Analysis of Heterobifunctional Multivalent Phage Capsid Inhibitors Blocking the Entry of Influenza Virus |
title | Design and Functional Analysis of Heterobifunctional
Multivalent Phage Capsid Inhibitors Blocking the Entry of Influenza
Virus |
title_full | Design and Functional Analysis of Heterobifunctional
Multivalent Phage Capsid Inhibitors Blocking the Entry of Influenza
Virus |
title_fullStr | Design and Functional Analysis of Heterobifunctional
Multivalent Phage Capsid Inhibitors Blocking the Entry of Influenza
Virus |
title_full_unstemmed | Design and Functional Analysis of Heterobifunctional
Multivalent Phage Capsid Inhibitors Blocking the Entry of Influenza
Virus |
title_short | Design and Functional Analysis of Heterobifunctional
Multivalent Phage Capsid Inhibitors Blocking the Entry of Influenza
Virus |
title_sort | design and functional analysis of heterobifunctional
multivalent phage capsid inhibitors blocking the entry of influenza
virus |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305970/ https://www.ncbi.nlm.nih.gov/pubmed/35759354 http://dx.doi.org/10.1021/acs.bioconjchem.2c00166 |
work_keys_str_mv | AT adamlutz designandfunctionalanalysisofheterobifunctionalmultivalentphagecapsidinhibitorsblockingtheentryofinfluenzavirus AT mullereva designandfunctionalanalysisofheterobifunctionalmultivalentphagecapsidinhibitorsblockingtheentryofinfluenzavirus AT ludwigkai designandfunctionalanalysisofheterobifunctionalmultivalentphagecapsidinhibitorsblockingtheentryofinfluenzavirus AT klenksimon designandfunctionalanalysisofheterobifunctionalmultivalentphagecapsidinhibitorsblockingtheentryofinfluenzavirus AT lausterdaniel designandfunctionalanalysisofheterobifunctionalmultivalentphagecapsidinhibitorsblockingtheentryofinfluenzavirus AT liesesusanne designandfunctionalanalysisofheterobifunctionalmultivalentphagecapsidinhibitorsblockingtheentryofinfluenzavirus AT herrmannandreas designandfunctionalanalysisofheterobifunctionalmultivalentphagecapsidinhibitorsblockingtheentryofinfluenzavirus AT hackenbergerchristianpr designandfunctionalanalysisofheterobifunctionalmultivalentphagecapsidinhibitorsblockingtheentryofinfluenzavirus |